[New medical treatments for polycystic ovary syndrome]

J Gynecol Obstet Biol Reprod (Paris). 2003 Dec;32(8 Pt 1):685-91.
[Article in French]

Abstract

Polycystic ovary syndrome (PCO) is a polygenic disease worsened by obesity and environmental factors. PCO is characterized by chronic menstrual irregularity and hypofertility and metabolic disorders. Routine care includes appropriate diet, exercise and annual check-up to search for high blood pressure. Laboratory tests should include a lipid profile and fasting serum glucose. Insulin sensitizing drugs improve the metabolic pattern, induce ovulation and increase pregnancy rate. Here, we review the different therapeutic options for these patients.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Blood Glucose / metabolism
  • Diabetes Mellitus / prevention & control
  • Female
  • Humans
  • Infertility, Female / therapy*
  • Insulin / blood
  • Insulin Resistance*
  • Lipid Metabolism
  • Menstrual Cycle / physiology*
  • Obesity / prevention & control
  • Ovulation Induction / methods
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / physiopathology*
  • Polycystic Ovary Syndrome / therapy*
  • Pregnancy
  • Pregnancy Rate

Substances

  • Blood Glucose
  • Insulin